-
Interpreting Anticancer Drug Responses In Vitro
2026-09-15
Hannah R. Schwartz’s dissertation separates growth inhibition from actual cell killing, showing that anticancer drugs can affect proliferation and death with different magnitudes and timing. This framework supports more informative viability studies by pairing relative and fractional viability with time-resolved and orthogonal cell-death measurements.
-
25-Hydroxycholesterol–AMPK Axis in TAMs
2026-09-15
Xiao et al. identify CH25H-derived 25-hydroxycholesterol as an immunometabolic checkpoint that activates lysosomal AMPKα through a GPR155–mTORC1 pathway in tumor-associated macrophages. The study connects this pathway to STAT6 phosphorylation, ARG1 production, macrophage immunosuppression, and improved anti-tumor responses after CH25H targeting, including in combination with anti-PD-1 therapy.
-
Zika Virus STAT2 Degron: Mechanism and Methods
2026-09-14
Parisien and colleagues identify the human STAT2 coiled-coil domain as both necessary and sufficient for Zika virus NS5 interaction and proteasome-dependent STAT2 loss. Their mapping of the first two coiled-coil alpha-helices defines a focused viral immune-evasion determinant and suggests a framework for testing host–virus protein interfaces.
-
Rottlerin: From PKCδ Mechanism to Translation
2026-09-14
Rottlerin offers translational researchers a valuable way to interrogate PKCδ-linked biology across proliferation, apoptosis, endothelial barrier function, and cellular entry. Its strongest value is not as a universal pathway switch, but as a mechanistic probe that can connect biochemical inhibition with time-resolved phenotypes. This article examines how to position Rottlerin as a PKC inhibitor, interpret its cancer and cell-entry evidence, manage selectivity and formulation constraints, and design experiments that remain credible when moving from discovery biology toward translational strategy.
-
JC-1 Mitochondrial Membrane Potential Assay
2026-09-13
The JC-1 Mitochondrial Membrane Potential Assay Kit reveals how mitochondrial depolarization contributes to treatment-induced cell death. This guide connects ratiometric ΔΨm measurement with mechanistic interpretation of hypoxia-activated cancer therapies.
-
Ciclesonide Workflows for Asthma Research
2026-09-12
Build more informative respiratory assays by separating Ciclesonide prodrug activation from the high-potency activity of desisobutyryl-ciclesonide. This workflow combines formulation control, bronchial-cell conversion studies, glucocorticoid receptor readouts, and carefully bounded lessons from emerging ERAD-based degradation research.
-
RepSox ALK5 Inhibitor for iPSC Platelet Workflows
2026-09-12
RepSox provides a selective way to perturb ALK5 and TGF-β signaling while researchers optimize induced pluripotent stem cell reprogramming and lineage differentiation. This article separates validated hiPSC-to-platelet advances from RepSox-specific workflow hypotheses, with practical dosing, assay selection, and troubleshooting guidance.
-
Stable-Isotope UHPLC–MS/MS for Methylated Purines
2026-09-11
Zhang, Zhang, and Wang developed a stable isotope-diluted UHPLC–ESI-MS/MS workflow that improves the sensitivity and selectivity of intracellular methylated purine nucleoside measurements. Ammonium bicarbonate-enhanced ionization, chromatographic isomer separation, methanol extraction, and solid-phase cleanup enabled accurate quantification of low-abundance metabolites in 293T cells.
-
Cell Cycle Assay Kit (Catalog No. K2263)
2026-09-11
A practical, evidence-linked guide to using the Cell Cycle Assay Kit (Catalog No. K2263) for DNA-content profiling, cell cycle progression analysis, and apoptosis detection by sub-G1 peak. The article connects SKU K2263 with experimental design, RNase A propidium iodide staining, data interpretation, and evidence-based product selection.
-
Dual TLR2/4 Inhibition in Oxygen-Induced Retinopathy
2026-09-10
Dayoub and colleagues evaluated AVR-121 and AVR-123 as dual TLR2/4 inhibitors across inflammatory, endothelial, and oxygen-induced retinopathy models. AVR-123 reduced vaso-obliteration, pathological angiogenesis, and inflammatory responses in phase-specific mouse experiments without suppressing the physiological VEGF response, supporting pathway-directed intervention as a complement to anti-VEGF treatment.
-
Why SOD Activity Matters in Redox Translation
2026-09-10
A mechanistic and strategic guide to using the Superoxide Dismutase Activity Assay Kit in oxidative stress research, with practical lessons from known ROS measurement confounders and guidance for translational study design.
-
γH2AX in FLASH Radiotherapy: From Signal to Strategy
2026-09-09
A translational framework for using the γH2AX DNA Damage Detection Kit to connect double-strand break biology with radiosensitizer evaluation, FLASH radiotherapy design, and preclinical decision-making.
-
Cannabidiol, Orofacial Pain, and Affective Circuits
2026-09-09
This 2026 Brain Research Bulletin study shows that cannabidiol reduces both inflammatory orofacial nociception and pain-related affective and cognitive deficits in mice. Its combined behavioral, molecular, endocannabinoid, and serotonergic analyses provide a framework for separating peripheral analgesia from central emotional effects and for designing receptor-level follow-up studies.
-
SERCA-Mediated ER Stress in HSC Mobilization
2026-09-08
Li et al. identify SERCA-mediated endoplasmic reticulum stress as a regulator of hematopoietic stem cell mobilization. Their in vivo and molecular data connect SERCA inhibition by BHQ to the CaMKII-STAT3-CXCR4 axis, offering a mechanistic framework for improving stem cell collection while highlighting the need for careful calcium and stress-response control.
-
E. coli Uracil-DNA Glycosylase (UDG) Protocol
2026-09-08
E. coli Uracil-DNA Glycosylase (UDG), SKU K1107, removes uracil residues from single- and double-stranded DNA to support PCR product contamination elimination and related DNA repair enzyme workflows. It should be used for research DNA workflows, not RNA substrates, oligonucleotides shorter than six bases, or diagnostic and medical applications.